“I don’t know how you people sleep at night,” Rep. Jan Schakowsky, D-Ill., told the executives, according to STAT. “You’re in trouble if you think you can just outtalk us without any transparency, without any accountability, I just want you to know your days are numbered.”
Executives from Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, OptumRx and CVS Health testified for their companies.
Throughout the hearing, the insulin manufacturers and pharmacy benefit managers blamed each other for the rising costs of insulin, and the blame game appeared to frustrate both Republicans and Democrats, who urged the executives to focus on solutions.
“I want to congratulate all of you because you have done something here today that we have been trying to do in Congress,” said Rep. Buddy Carter, R-Ga., according to STAT. “And that is to create bipartisanship.”
More articles on pharmacy:
PBM hearing should prompt bill to ban ‘secrecy’ in drug industry, senator says
Republicans tell drugmakers that complying with House probe could hurt their stock prices
Hawaii primary care network opens in-house pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
